Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...
In the Phase III results presented and published today, olezarsen demonstrated rapid, substantial and significant reductions in triglycerides by up to 72% on top of standard of care and reduced the ...
Scientists at the FMI and the University of California-Santa Cruz have found that similar molecular machineries control daily circadian rhythms and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback